Related Experiment Video
Updated: Jan 11, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
FCGR3A Drives Innate Immune Activation via M1 Macrophage Polarization in Pediatric IBD
Xi Liu1, Zhishan Liang2,3
1Department of Pediatrics, The People's Hospital of Guangzhou Nansha District, Guangzhou, China.
Introduction:
This study investigated the role of FCGR3A in pediatric inflammatory bowel disease (IBD) through integrated transcriptomic analysis and experimental validation, aiming to provide new mechanistic insights and therapeutic strategies.
Methods:
Transcriptomic datasets of pediatric IBD were obtained from the Gene Expression Omnibus database, and differentially expressed genes (DEGs) were identified. Weighted gene co-expression network analysis (WGCNA) was applied to screen disease-related modules, followed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses of overlapping DEGs. Hub genes were determined using protein-protein interaction networks, least absolute shrinkage and selection operator regression, and random forest algorithms. Their expression was verified by meta-analysis across multiple datasets, and diagnostic value was assessed using receiver operating characteristic (ROC) curves. The relationship between hub genes and immune infiltration was further explored. Functional assays included lipopolysaccharide (LPS)-stimulated intestinal epithelial and THP-1 macrophage models, as well as a dextran sulfate sodium (DSS)-induced murine colitis model.
Results:
WGCNA revealed 370 module genes associated with pediatric IBD, enriched in inflammatory pathways. Seven candidate genes were identified, among which FCGR3A showed a strong association with pediatric IBD. Immune infiltration analysis demonstrated that FCGR3A expression correlated with M1 macrophage enrichment. In vitro, FCGR3A was upregulated in LPS-induced epithelial cells, and its knockdown inhibited M1 macrophage polarization. In vivo, FCGR3A was highly expressed in DSS-induced murine colitis, promoting M1 polarization and disease progression. ROC analysis indicated strong predictive value (AUC = 0.968).
Conclusion:
FCGR3A may serve as a pivotal regulator in pediatric IBD by driving M1 macrophage polarization, representing a promising biomarker and potential therapeutic target.
More Related Videos
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...